Publications. Personalized Medicine Matthijs Versteegh 10/30/23 Personalized Medicine Matthijs Versteegh 10/30/23 Cost–effectiveness of alternative NTRK testing strategies in cancer patients followed by histology-independent therapy with entrectinib: an analysis of three European countries Read More Personalized Medicine Matthijs Versteegh 10/3/23 Personalized Medicine Matthijs Versteegh 10/3/23 HEcoPerMed, personalized medicine from a health economic perspective: lessons learned and potential opportunities ahead Read More Personalized Medicine Matthijs Versteegh 8/14/23 Personalized Medicine Matthijs Versteegh 8/14/23 Budget impact and transferability of cost–effectiveness of DPYD testing in metastatic breast cancer in three health systems Read More
Personalized Medicine Matthijs Versteegh 10/30/23 Personalized Medicine Matthijs Versteegh 10/30/23 Cost–effectiveness of alternative NTRK testing strategies in cancer patients followed by histology-independent therapy with entrectinib: an analysis of three European countries Read More
Personalized Medicine Matthijs Versteegh 10/3/23 Personalized Medicine Matthijs Versteegh 10/3/23 HEcoPerMed, personalized medicine from a health economic perspective: lessons learned and potential opportunities ahead Read More
Personalized Medicine Matthijs Versteegh 8/14/23 Personalized Medicine Matthijs Versteegh 8/14/23 Budget impact and transferability of cost–effectiveness of DPYD testing in metastatic breast cancer in three health systems Read More
